TYLER HOBBS: Open Payments
NPI 1528542644 · PROVO, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,727 in 142 payments from 18 companies in 2025. Trend: 2023 $3,447 · 2024 $3,566 · 2025 $2,727
Food & beverage: $2,670Education: $57
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 22 | $669 |
| Amgen Inc. | 35 | $541 |
| ABBVIE INC. | 24 | $300 |
| Janssen Biotech, Inc. | 14 | $248 |
| Novartis Pharmaceuticals Corporation | 12 | $248 |
| GlaxoSmithKline, LLC. | 6 | $118 |
| Fresenius Kabi USA, LLC | 5 | $104 |
| Mallinckrodt Hospital Products Inc. | 4 | $92 |
| Organon LLC | 4 | $80 |
| GENZYME CORPORATION | 3 | $68 |
Products named: Bimzelx, TREMFYA, RINVOQ, ENBREL, COSENTYX, EVENITY, BENLYSTA, TAVNEOS.
Industry payments across UT — which companies pay providers there.
